Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
for
Epstein-Barr Virus Infections,
Location: Valhalla NY, Philadelphia PA, Baltimore MD, Columbus OH,
Sponsor: New York Medical College
Sex: All
Age: 0 - 70+
Code: NCT03266653
Phase2, Recruiting
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
for
Chronic Hepatitis B
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 65
Code: NCT06092333
Phase2, Recruiting
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
for
Ovarian Cancer, Endometrial Cancer
Location: Baltimore MD
Sponsor: Sinai Hospital of Baltimore
Sex: Female
Age: 18 - 70+
Code: NCT02188550
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Robot Aided Rehabilitation - Intervention
for
Stroke
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT02359253
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT05958654
Recruiting
A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis
for
Osteoarthritis, Hip, Osteoarthritis, Degeneration
Location: North Bethesda MD
Sponsor: Regenerative Orthopedics and Sports Medicine
Sex: All
Age: 30 - 65
Code: NCT04241354
Phase1, Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Boston MA, Providence RI, Lebanon NH, Jamaica NY,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
Change in MAPSE During Treatment of Sepsis
for
Sepsis
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT05634733
Recruiting
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
for
Chronic Granulomatous Disease
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 4 - 65
Code: NCT05463133
Phase1, Phase2, Recruiting
Induction of Labor in Morbidly Obese Patients
for
Morbid Obesity, Pregnancy
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: Female
Age: 18+
Code: NCT06199154
Early_phase1, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma